Skip to content

Conjunctival Transpositional Surgery for Primary Pterygium

Conjunctival Transpositional Pterygium Surgery: A Prospective Single-Arm Interventional Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07343011
Enrollment
70
Registered
2026-01-15
Start date
2025-05-21
Completion date
2027-01-01
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pterygium of the Conjunctiva and Cornea

Brief summary

This prospective single-arm interventional study evaluates the recurrence rate and functional outcomes following conjunctival transpositional pterygium surgery without bare sclera formation. The technique involves mobilization and transposition of the pterygium tissue while preserving Tenon's layer and avoiding adjunctive therapies.

Interventions

PROCEDUREConjunctival Transpositional Pterygium Surgery

A conjunctival incision was created at the upper and lower limbus to allow adequate tissue mobilization. The pterygium tissue is dissected off the corneal surface without complete excision or creation of a bare sclera defect. The fibrovascular tissue is mobilized and transposed inferiorly within the subconjunctival plane and secured with absorbable sutures. Tenon's tissue is preserved, and no adjunctive therapy is used.

Sponsors

Zahedan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 years or older * Primary pterygium involving the cornea * Ability to provide informed consent

Exclusion criteria

* Recurrent pterygium * Previous ocular surface surgery * Active ocular infection or inflammation * Severe ocular surface disease

Design outcomes

Primary

MeasureTime frameDescription
Pterygium Recurrence12 monthsRecurrence is defined as fibrovascular regrowth toward the cornea or surgical failure.

Secondary

MeasureTime frameDescription
Visual Acuity12 monthsChange in visual acuity measured in logMAR units.
Refractive Astigmatism12 monthsChange in refractive astigmatism measured as cylindrical power in diopters.

Countries

Iran

Contacts

Primary ContactMohammed Arish, MD, FRCS
mohammad.erish@zaums.ac.ir09151419155

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026